Brivanib (BMS-582664) in advanced soft-tissue sarcoma (STS): Biomarker and subset results of a phase II randomized discontinuation trial.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: G. K. Schwartz, R. G. Maki, M. J. Ratain, S. D. Undevia, R. L. Jones, C. M. Rudin, L. L. Siu, B. Brockstein, D. Khayat, T. Gil, M. J. De Jonge, M. B. Sawyer, T. R. J. Evans, J. Medioni, P. J. O'Dwyer, C. Hartman, V. Poulart, I. B. Walters
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2560569134